192 related articles for article (PubMed ID: 15790300)
1. Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy.
Donnelly RF; McCarron PA; Woolfson AD
Photochem Photobiol; 2005; 81(4):750-67. PubMed ID: 15790300
[TBL] [Abstract][Full Text] [Related]
2. Novel patch-based systems for the localised delivery of ALA-esters.
Morrow DI; McCarron PA; Woolfson AD; Juzenas P; Juzeniene A; Iani V; Moan J; Donnelly RF
J Photochem Photobiol B; 2010 Oct; 101(1):59-69. PubMed ID: 20634088
[TBL] [Abstract][Full Text] [Related]
3. Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years.
Baptista J; Martinez C; Leite L; Cochito M
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):693-7. PubMed ID: 16836497
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application.
Schacht V; Szeimies RM; Abels C
Photochem Photobiol Sci; 2006 May; 5(5):452-8. PubMed ID: 16685321
[TBL] [Abstract][Full Text] [Related]
5. Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.
McLoone N; Donnelly RF; Walsh M; Dolan OM; McLoone S; McKenna K; McCarron PA
Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):183-90. PubMed ID: 18717959
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid.
Hayami J; Okamoto H; Sugihara A; Horio T
J Dermatol; 2007 May; 34(5):320-7. PubMed ID: 17408441
[TBL] [Abstract][Full Text] [Related]
8. The advantages of aminolevulinic acid photodynamic therapy in dermatology.
Taylor EL; Brown SB
J Dermatolog Treat; 2002; 13 Suppl 1():S3-11. PubMed ID: 12060511
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy using direct-current pulsed iontophoresis for 5-aminolevulinic acid application.
Mizutani K; Watanabe D; Akita Y; Akimoto M; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):280-2. PubMed ID: 19747250
[TBL] [Abstract][Full Text] [Related]
10. [Topical photodynamic therapy in dermatology].
Grob M; Schmid-Grendelmeier P
Ther Umsch; 1998 Aug; 55(8):529-32. PubMed ID: 9757821
[TBL] [Abstract][Full Text] [Related]
11. Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.
Pierre MB; Ricci E; Tedesco AC; Bentley MV
Pharm Res; 2006 Feb; 23(2):360-6. PubMed ID: 16341572
[TBL] [Abstract][Full Text] [Related]
12. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy.
Donnelly RF; Morrow DI; McCarron PA; Woolfson AD; Morrissey A; Juzenas P; Juzeniene A; Iani V; McCarthy HO; Moan J
J Control Release; 2008 Aug; 129(3):154-62. PubMed ID: 18556084
[TBL] [Abstract][Full Text] [Related]
13. Development of a stable solution of 5-aminolaevulinic acid for intracutaneous injection in photodynamic therapy.
de Blois AW; Grouls RJ; Ackerman EW; Wijdeven WJ
Lasers Med Sci; 2002; 17(3):208-15. PubMed ID: 12181635
[TBL] [Abstract][Full Text] [Related]
14. Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis.
Donnelly RF; McCarron PA; Lightowler JM; Woolfson AD
J Control Release; 2005 Mar; 103(2):381-92. PubMed ID: 15763621
[TBL] [Abstract][Full Text] [Related]
15. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
16. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
Tsai JC; Chen IH; Wong TW; Lo YL
Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic Therapy of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array.
Tsai JC; Chiang CP; Chen HM; Huang SB; Wang CW; Lee MI; Hsu YC; Chen CT; Tsai T
Lasers Surg Med; 2004; 34(1):18-24. PubMed ID: 14755421
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
Chen HM; Yu CH; Tu PC; Yeh CY; Tsai T; Chiang CP
Lasers Surg Med; 2005 Aug; 37(2):114-22. PubMed ID: 16037967
[TBL] [Abstract][Full Text] [Related]
19. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy.
Oh EK; Jin SE; Kim JK; Park JS; Park Y; Kim CK
Eur J Pharm Sci; 2011 Sep; 44(1-2):149-57. PubMed ID: 21782942
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review).
Friesen SA; Hjortland GO; Madsen SJ; Hirschberg H; Engebraten O; Nesland JM; Peng Q
Int J Oncol; 2002 Sep; 21(3):577-82. PubMed ID: 12168102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
